
Alok Narain
About Alok Narain
Data last updated:
Alok Narain is a Director at Treadstone Allianz Private Limited (since 1987) and Director at Oasis Pharmaceuticals Limited (since 1994). The companies operate in Healthcare and Pharma. The largest current company by reported revenue is Treadstone Allianz Private Limited at ₹15.63 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Feb 1987 | 1987 | ₹15.63 Cr (FY 2025) | Active | |
| Director | 31 Jan 1994 | 1994 | Active |
Board colleagues of Alok Narain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anil Kumar Maskara | 00641533 | Treadstone Allianz Private Limited | Director |
| Avinash Lohia | 07104115 | Oasis Pharmaceuticals Limited | Director |
| Swati Pasari | 10217254 | Oasis Pharmaceuticals Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Alok Narain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alok Narain
Alok Narain currently holds 2 directorships: Treadstone Allianz Private Limited (Director, since 25 Feb 1987, revenue ₹15.63 Cr (FY 2025)); Oasis Pharmaceuticals Limited (Director, since 31 Jan 1994).
Alok Narain was first appointed on 25 Feb 1987 as Director at Treadstone Allianz Private Limited. The most recent appointment on record is 31 Jan 1994 at Oasis Pharmaceuticals Limited.
The current boards of Alok Narain's companies include Anil Kumar Maskara (Treadstone Allianz Private Limited), Avinash Lohia (Oasis Pharmaceuticals Limited), Swati Pasari (Oasis Pharmaceuticals Limited).